RegisterLogin

ESI-08

CAT: 0804-HY-136172-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-136172-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
ESI-08 is a potent and selective EPAC antagonist, which can completely inhibit both EPAC1 and EPAC2 (IC50 of 8.4 μM) activity. ESI-08 selectively blocks cAMP-induced EPAC activation, but does not inhibit cAMP-mediated PKA activation[1].
CAS Number
[301177-43-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Metabolic Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/esi-08.html
Purity
98.74
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N#CC1=C(C2CCCCC2)N=C(SCC3=CC(C)=CC=C3C)NC1=O
Molecular Formula
C20H23N3OS
Molecular Weight
353.48
Precautions
H302, H315, H319
References & Citations
[1]Chen H, et al. 5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP. Bioorg Med Chem Lett. 2012 Jun 15;22 (12) :4038-43.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-117656-01ESI-05
HY-16704-01ESI-09
HY-165152-01KAS 08
HY-P10477CT-08
HY-U00371-01AR-08
HY-139144-01YM-08
HY-112902-01OGG1-IN-08
HY-163917SalA-VS-08
HY-161167MM-02-08
HY-108466-01Ro 08-2750

Alternative Products

CatalogName
BA5778-1ESI-08
A24573-5ESI-08 5mg
A24573-50ESI-08 50mg
A24573-10ESI-08 10mg
A24573-100ESI-08 100mg
M22840-01ESI-05
M13808-01ESI-09
6320/25ESI 05
255266-01ESI 09

Popular Products